These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2782767)

  • 21. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease.
    Saetta M; Di Stefano A; Turato G; Facchini FM; Corbino L; Mapp CE; Maestrelli P; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):822-6. PubMed ID: 9517597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group.
    Brand PL; Kerstjens HA; Postma DS; Sterk PJ; Quanjer PH; Sluiter HJ; Dijkman JH; van Herwaarden CL; Hilvering C; Jansen HM
    Eur Respir J; 1992 Jan; 5(1):21-31. PubMed ID: 1533595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung hyperinflation and flow limitation in chronic airway obstruction.
    Pellegrino R; Brusasco V
    Eur Respir J; 1997 Mar; 10(3):543-9. PubMed ID: 9072982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical course of the ventilatory function in COPD: analytical study of 160 cases].
    Battikh MH; Ben Sayah MM; Joobeur S; Naouar R; Maatallah A; Rouatbi N; Ben Salem K; El Kamel A
    Tunis Med; 2004 Aug; 82(8):735-41. PubMed ID: 15532768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease.
    Papi A; Romagnoli M; Baraldo S; Braccioni F; Guzzinati I; Saetta M; Ciaccia A; Fabbri LM
    Am J Respir Crit Care Med; 2000 Nov; 162(5):1773-7. PubMed ID: 11069811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Forced expiratory volume in 1 second (FEV1)--a respiratory physiological measurement of considerable prognostic value].
    Vestbo J; Lange P
    Ugeskr Laeger; 1991 Aug; 153(33):2292-5. PubMed ID: 1781049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional impairment of mucociliary clearance in chronic obstructive pulmonary disease.
    Smaldone GC; Foster WM; O'Riordan TG; Messina MS; Perry RJ; Langenback EG
    Chest; 1993 May; 103(5):1390-6. PubMed ID: 8486016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrinsic positive end-expiratory pressure in ambulatory patients with airways obstruction.
    Aldrich TK; Hendler JM; Vizioli LD; Park M; Multz AS; Shapiro SM
    Am Rev Respir Dis; 1993 Apr; 147(4):845-9. PubMed ID: 8466118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal analysis of the effects of smoking onset and cessation on pulmonary function.
    Sherrill DL; Holberg CJ; Enright PL; Lebowitz MD; Burrows B
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):591-7. PubMed ID: 8118623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucociliary clearance and airways obstruction in smokers, ex-smokers and normal subjects who never smoked.
    Vastag E; Matthys H; Köhler D; Gronbeck L; Daikeler G
    Eur J Respir Dis Suppl; 1985; 139():93-100. PubMed ID: 3862617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal evaluation of the association between pulmonary function and total serum IgE.
    Sherrill DL; Lebowitz MD; Halonen M; Barbee RA; Burrows B
    Am J Respir Crit Care Med; 1995 Jul; 152(1):98-102. PubMed ID: 7599870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group.
    Vestbo J; Prescott E; Lange P
    Am J Respir Crit Care Med; 1996 May; 153(5):1530-5. PubMed ID: 8630597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small airways dimensions in asthma and in chronic obstructive pulmonary disease.
    Kuwano K; Bosken CH; Paré PD; Bai TR; Wiggs BR; Hogg JC
    Am Rev Respir Dis; 1993 Nov; 148(5):1220-5. PubMed ID: 8239157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe chronic airflow obstruction: can corticosteroids slow down progression?
    Postma DS; Steenhuis EJ; van der Weele LT; Sluiter HJ
    Eur J Respir Dis; 1985 Jul; 67(1):56-64. PubMed ID: 4054257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [FEV1 after three years of observation in patients with bronchial asthma and patients with chronic obstructive pulmonary disease].
    Zagdańska R; Grzelewska-Rzymowska I
    Pneumonol Alergol Pol; 2005; 73(2):142-7. PubMed ID: 16756143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Course and prognosis of chronic obstructive lung disease over 5 and 10 years].
    Brändli O; Langloh P; Plangger M; Dreher D
    Schweiz Med Wochenschr; 1988 Sep; 118(37):1314-20. PubMed ID: 3175577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of inspiratory load in the assessment of severity of airways obstruction and its correlation with CO2 retention in chronic obstructive pulmonary disease.
    Molho M; Shulimzon T; Benzaray S; Katz I
    Am Rev Respir Dis; 1993 Jan; 147(1):45-9. PubMed ID: 8420429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults.
    Postma DS; Lebowitz MD
    Arch Intern Med; 1995 Jul; 155(13):1393-9. PubMed ID: 7794088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample.
    Dodge R; Cline MG; Burrows B
    Am Rev Respir Dis; 1986 Jun; 133(6):981-6. PubMed ID: 3717770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A reexamination of risk factors for ventilatory impairment.
    Burrows B; Knudson RJ; Cline MG; Lebowitz MD
    Am Rev Respir Dis; 1988 Oct; 138(4):829-36. PubMed ID: 3202457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.